Posted on 5 月 11, 20205/11/20
FDA OK’s AZ & Merck’s Lynparza Plus Bevacizumab in HRD-Positive Ovarian Cancer
Posted on 5 月 11, 20205/11/20
EVERSANA to present at the Virtual ISPOR 2020
Posted on 5 月 6, 20205/6/20
Biosimilars Saved Spain 2,400 Million Euros Between 2009 and 2020
Posted on 5 月 6, 20205/6/20
Brazil in Talks to Gain Access to Gilead’s Remdesivir
Posted on 5 月 4, 20205/4/20
UK National Clinical Trial Initiative Could Fast-Track COVID-19 Treatments
Posted on 5 月 4, 20205/4/20
EVERSANA Appoints Kelly Baker to Chief Financial Officer
Posted on 5 月 4, 20205/4/20
Pricentric Insights: China’s Interim Measures for NRDL, BMI Administration
Posted on 5 月 4, 20205/4/20
